Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. scores highest on Price (49) and lowest on Nitro (16). Its PosiPenta is 35.76 out of 100, weaker than most similar companies.
On the Penta Grid this week, Citius Pharmaceuticals, Inc. is Grid #648 of 836 in the Healthcare sector in United States, and Grid #3,237 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. | 35.76 | 49 | 35 | 16 | 43 | 36 |
| GT Biopharma, Inc. | 40.36 | 30 | 38 | 29 | 57 | 48 |
| Caring Brands, Inc. | 41.34 | 0 | 54 | 68 | 38 | 47 |
| Passage Bio, Inc. | 22.70 | 24 | 17 | 18 | 16 | 38 |
| BioVie Inc. | 39.80 | 39 | 47 | 34 | 43 | 35 |
| Lisata Therapeutics, Inc. | 40.49 | 35 | 40 | 19 | 58 | 50 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.26 |
| P/B ratio | 0.19 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹-136.39 |
NNitro
| Price | 43.57 |
| 52-week high | 207.43 |
| 52-week low | 42.62 |
| Fall from 52-week high | 79.0% |
TTorque
| Return on equity (ROE) | -81.09% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | 1.00 |
| Market cap | ₹119 Cr |
| Insider holding | 1.79% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Citius Pharmaceuticals, Inc.'s PosiPenta score?
Citius Pharmaceuticals, Inc.'s PosiPenta is 35.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Citius Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Citius Pharmaceuticals, Inc. is Grid #648 of 836 in the Healthcare sector in United States, and Grid #3,237 of 3,999 in United States.
Which PosiPenta pillar is strongest for Citius Pharmaceuticals, Inc.?
Price (valuation), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Citius Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 16 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.